Engagement

Strategy and backtest review

An independent review of a strategy before it takes capital - or after it stops behaving the way the backtest said it would. I look at the research, the data, and the code behind it, not just the equity curve. The output is a written assessment you can hand to an IC, an allocator, or your own team.

Timing2-3 weeks FeeFrom $7,500 Book a 30-minute scoping call

How it works

Start with the decision. Examine the evidence. Put the conclusion in writing.

01

Scope the decision

We agree the decision to be made, the evidence required, access, and the people involved before the engagement begins.

02

Review the evidence

I work through the research, data, code, systems, and claims relevant to the agreed scope.

03

Put the answer in writing

Findings, supporting evidence, priorities, and unresolved questions are delivered in writing and discussed with your team.

Scope

What I review

01

Data integrity

Sources, point-in-time correctness, corporate actions, survivorship.

In practice, this is where most reviews find their first material issue.

02

Lookahead and leakage

Timestamp alignment, feature construction, restatement handling.

03

Cost and execution model

Spread, impact, borrow, fill assumptions against realistic venues.

Many otherwise convincing backtests fail here first, at realistic size.

04

Statistical robustness

Parameter sensitivity, multiple-testing burden, out-of-sample discipline.

05

Capacity and liquidity

The AUM level at which the edge stops paying for itself.

06

Research-to-production parity

Whether the live system computes what the backtest computed.

Divergence between research and production code is common and rarely instrumented.

Output

Deliverables

  1. 01

    Written review (15-25 pages): findings, severity-ranked, with the evidence behind each

  2. 02

    Reproduced backtest under my own assumptions, with the delta explained

  3. 03

    Prioritised remediation list - what to fix before capital, what can wait

  4. 04

    90-minute walkthrough with your team

Decision

Outcome

You get a defensible answer to one question: does the available evidence support deploying capital, and under what assumptions? The review either provides independent evidence for proceeding within defined limits or identifies material weaknesses before they surface in live trading.

Engagement

Start with the decision you need to make.

2-3 weeks. From $7,500. Final scope and fee are confirmed after a 30-minute call.

Book a 30-minute scoping call Email me